COMBIHALE-G CAP

Description

COMBIHALE-G Capsule combines Glycopyrronium Bromide, a long-acting muscarinic antagonist (LAMA), and Formoterol Fumarate, a long-acting beta-2 agonist (LABA), to provide effective bronchodilation for patients with chronic obstructive pulmonary disease (COPD).

Glycopyrronium works by blocking muscarinic receptors in the airways, reducing bronchoconstriction, while formoterol relaxes airway smooth muscle, improving airflow. This dual bronchodilator action helps reduce symptoms, improve lung function, and decrease COPD exacerbations. The capsules are designed for inhalation via a dry powder inhaler device, ensuring targeted delivery to the lungs.

Key Benefits:

• Dual bronchodilation with LAMA + LABA combination

• Improves airflow and lung function

• Helps reduce COPD symptoms and exacerbations

• Convenient capsule form for inhalation via dry powder inhaler

Indications:

• Maintenance treatment of COPD

Dosage:
As directed by the physician, typically inhaling one capsule twice daily using a dry powder inhaler.

Precautions:
Not for acute bronchospasm relief. Use under medical supervision. Possible side effects include dry mouth, headache, and tremors.